1 Guidance

1 Guidance

1.1 Aflibercept solution for injection is recommended as an option for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion only if the manufacturer provides aflibercept solution for injection with the discount agreed in the patient access scheme.

  • National Institute for Health and Care Excellence (NICE)